SC 13G/A | 2024-03-18 | Tarriff Scott | EAGLE PHARMACEUTICALS, INC. | 2,470,570 | 17.6% | EDGAR |
SC 13D | 2024-02-14 | Graves Michael | EAGLE PHARMACEUTICALS, INC. | 238,660 | 1.8% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | EAGLE PHARMACEUTICALS, INC. | 638,124 | 4.9% | EDGAR |
SC 13G/A | 2024-02-13 | JANUS HENDERSON GROUP PLC | EAGLE PHARMACEUTICALS, INC. | 775,525 | 6.0% | EDGAR |
SC 13G | 2024-02-12 | BRANDES INVESTMENT PARTNERS, LP | EAGLE PHARMACEUTICALS, INC. | 745,079 | 5.7% | EDGAR |
SC 13G | 2024-02-07 | HIRSCHMAN ORIN | EAGLE PHARMACEUTICALS, INC. | 1,061,509 | 8.2% | EDGAR |
SC 13G/A | 2024-01-26 | BlackRock Inc. | EAGLE PHARMACEUTICALS, INC. | 984,075 | 7.6% | EDGAR |
SC 13G/A | 2024-01-22 | STATE STREET CORP | EAGLE PHARMACEUTICALS, INC. | - | 1.7% | EDGAR |
SC 13G/A | 2023-07-07 | BlackRock Inc. | EAGLE PHARMACEUTICALS, INC. | 1,009,090 | 7.7% | EDGAR |
SC 13G/A | 2023-02-14 | Tarriff Scott | EAGLE PHARMACEUTICALS, INC. | 2,533,457 | 18.1% | EDGAR |
SC 13G/A | 2023-02-10 | JANUS HENDERSON GROUP PLC | EAGLE PHARMACEUTICALS, INC. | 1,229,872 | 9.4% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | EAGLE PHARMACEUTICALS, INC. | 763,807 | 5.9% | EDGAR |
SC 13G/A | 2023-02-03 | STATE STREET CORP | EAGLE PHARMACEUTICALS, INC. | - | 7.3% | EDGAR |
SC 13G/A | 2023-01-26 | BlackRock Inc. | EAGLE PHARMACEUTICALS, INC. | 1,872,901 | 14.4% | EDGAR |
SC 13G/A | 2023-01-20 | BlackRock Inc. | EAGLE PHARMACEUTICALS, INC. | 1,872,901 | 14.4% | EDGAR |
SC 13G/A | 2022-02-14 | Park West Asset Management LLC | EAGLE PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-14 | Tarriff Scott | EAGLE PHARMACEUTICALS, INC. | 2,419,974 | 17.6% | EDGAR |
SC 13G/A | 2022-02-11 | STATE STREET CORP | EAGLE PHARMACEUTICALS, INC. | - | 5.5% | EDGAR |
SC 13G/A | 2022-02-10 | JANUS HENDERSON GROUP PLC | EAGLE PHARMACEUTICALS, INC. | 1,528,152 | 11.8% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | EAGLE PHARMACEUTICALS, INC. | 760,468 | 5.9% | EDGAR |